Latest Breaking News On - Xilio therapeutics - Page 1 : vimarsana.com

Xilio Therapeutics, Inc. (NASDAQ:XLO – Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 379,500 shares, an increase of 600.2% from the March 31st total of 54,200 shares. Based on an average trading volume of 1,170,000 shares, […]

Gilead sciences incXilio therapeutics company profileXilio therapeutics incNasdaqXilio therapeuticsGet free reportGilead sciencesFree reportXilio therapeutics dailyNasdaq xloIxloMedicalStocksOptionsPutCall